Studies related to LDL-C and Policosanol

Comparative Lipid-lowering Effects Of Policosanol And Atorvastatin: A Randomized, Parallel, Double-blind, Placebo-controlled Trial

Effect None
Trial Design Double blind
Trial Length n/a
Number of Subjects 99
Gender n/a
Notes for this study:
Policosanol at 20mg per day was ineffective at lowering plasma lipid markers over a period of 12 weeks when compared to baseline and to placebo in a population of persons with high cholesterol. It showed no further additions when paired with statins

Full details on all 13 studies are available to Examine Plus members.

Already a member? Login now to access.